|
Index of reports
> Disability (8)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Rituxan (Rituximab) disability. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Rituxan side effects in 61 year old female
Reported by a pharmacist from Canada on 2012-07-23
Patient: 61 year old female
Reactions: Oedema Peripheral, Deafness
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Rituxan
Dosage: initial therapy
Indication: non-Hodgkin's Lymphoma
Clarithromycin
Indication: Product Used FOR Unknown Indication
Rituxan
Other drugs received by patient: Amoxicillin and Clavulanate Potassium; Cyclophosphamide; Prednisone; Doxorubicin Hydrochloride; Vincristine; Calcium; Vitamin D
Possible Rituxan side effects in 43 year old female
Reported by a pharmacist from Canada on 2012-07-09
Patient: 43 year old female, weighing 112.0 kg (246.4 pounds)
Reactions: Oral Candidiasis, Herpes Simplex, Mouth Ulceration, Oropharyngeal Pain, Neutropenia, Neoplasm
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-03
Patient: female
Reactions: Palmar-Plantar Erythrodysaesthesia Syndrome
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Cyclophosphamide
Start date: 2012-05-10
Cyclophosphamide
Start date: 2012-05-24
Doxorubicin HCL
Start date: 2012-05-24
Vincristine
Start date: 2012-05-10
Vincristine
Start date: 2012-05-24
Rituxan
Start date: 2012-05-24
Cyclophosphamide
Indication: B-Cell Lymphoma
Start date: 2012-04-26
Doxorubicin HCL
Start date: 2012-05-10
Vincristine
Indication: B-Cell Lymphoma
Start date: 2012-04-26
Rituxan
Start date: 2012-05-10
Prednisone
Indication: B-Cell Lymphoma
Start date: 2012-04-26
Rituxan
Indication: B-Cell Lymphoma
Start date: 2012-04-26
Prednisone
Start date: 2012-05-10
Doxorubicin HCL
Indication: B-Cell Lymphoma
Start date: 2012-04-26
Prednisone
Start date: 2012-05-24
Possible Rituxan side effects in 41 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-25
Patient: 41 year old female
Reactions: Drug Ineffective, Progressive Multifocal Leukoencephalopathy
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Rituxan
Dosage: on days 1 and 15
Start date: 2008-10-13
Methotrexate
Indication: Dermatomyositis
Start date: 2006-06-01
Infliximab
Indication: Dermatomyositis
Start date: 2008-03-13
End date: 2008-08-21
Rituxan
Indication: Dermatomyositis
Start date: 2009-08-13
Prednisone TAB
Administration route: Oral
Indication: Dermatomyositis
Start date: 2006-05-01
Rituxan
Dosage: this was the last dose prior to sae onset lot numbers for this dose was 720648, 720649.
Start date: 2008-10-27
Rituxan
Dosage: one days 1 and 15
Start date: 2007-07-01
Other drugs received by patient: Tramadol Hydrochl; Hydrochlorothiazide; Actonel; Folic Acid
Possible Rituxan side effects in female
Reported by a physician from United States on 2012-05-11
Patient: female, weighing 66.3 kg (145.8 pounds)
Reactions: Neurodermatitis, Deformity, Vulvar Dysplasia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Enbrel
Indication: Rheumatoid Arthritis
Start date: 2000-07-01
End date: 2002-02-01
Rituxan
Indication: Rheumatoid Arthritis
Start date: 2007-05-01
Other drugs received by patient: Arava; Kineret; Methotrexate; Tocilizumab
Possible Rituxan side effects in 41 year old female
Reported by a physician from United States on 2012-04-24
Patient: 41 year old female
Reactions: Drug Ineffective, Progressive Multifocal Leukoencephalopathy
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Rituxan
Indication: Dermatomyositis
Start date: 2009-08-13
Infliximab
Indication: Dermatomyositis
Start date: 2008-03-13
End date: 2008-08-21
Rituxan
Dosage: on days 1 and 15
Start date: 2008-10-13
Rituxan
Dosage: one days 1 and 15
Start date: 2007-07-01
Rituxan
Dosage: this was the last dose prior to sae onset lot numbers for this dose was 720648, 720649.
Start date: 2008-10-27
Prednisone TAB
Administration route: Oral
Indication: Dermatomyositis
Start date: 2006-05-01
Methotrexate
Indication: Dermatomyositis
Start date: 2006-06-01
Other drugs received by patient: Actonel; Folic Acid; Hydrochlorothiazide; Tramadol Hydrochl
Possible Rituxan side effects in 43 year old female
Reported by a physician from United States on 2012-04-03
Patient: 43 year old female, weighing 66.2 kg (145.7 pounds)
Reactions: Neurodermatitis, Deformity, Vulvar Dysplasia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Rituxan
Dosage: 1000 mg, q2wk
Indication: Rheumatoid Arthritis
Start date: 2007-05-01
Enbrel
Dosage: 25 mg, 2 times/wk
Indication: Rheumatoid Arthritis
Start date: 2000-07-01
End date: 2002-02-01
Other drugs received by patient: Kineret; Methotrexate; Tocilizumab; Arava
Possible Rituxan side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-09
Patient: female, weighing 70.3 kg (154.7 pounds)
Reactions: Oedema Peripheral, Dizziness, Atrial Fibrillation, Mobility Decreased
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Rituxan
Dosage: i.v.
Indication: Rheumatoid Arthritis
Start date: 2009-07-06
Rituxan
Dosage: i.v.
Indication: Rheumatoid Arthritis
Start date: 2009-06-18
|
